{"title": "After FDA Objections, 23andMe Won't Offer Health Information - Slashdot", "author": "Timothy Regulators-Know-Best Dept", "url": "https://science.slashdot.org/story/13/12/07/0051227/after-fda-objections-23andme-wont-offer-health-information", "hostname": "slashdot.org", "description": "sciencehabit writes \"The company 23andMe will no longer provide health information to people who purchase its DNA testing kit, it announced last night.The change was 'to comply with the U.S. Food and Drug Administration's directive to discontinue new consumer access during our regulatory review proc...", "sitename": "Slashdot", "date": "2013-12-06", "cleaned_text": "longer provide health information](http://news.sciencemag.org/biology/2013/12/dna-testing-company-wont-offer-health-information-anymore) to people who purchase its DNA testing kit, it announced last night.The change was 'to comply with the U.S. Food and Drug Administration's directive to discontinue new consumer access during our regulatory review process,' the statement said. While current customers will still have access to a 23andMe online database noting the health issues associated with their particular DNA, the company will not update that information, and customers who purchased its Personal Genome Service (PGS) on or after 22 November will receive only information about their ancestry and their raw genetic data without interpretation.\" It would be great to see a secondary market in this kind of analysis emerge. "}